22 January 2024
11 January 2024
We are excited to announce that ZoBio will join forces with Oncodesign Services (ODS), a leading Contract Research Organization (CRO) specializing in drug discovery and preclinical services with notable expertise in oncology and immuno-inflammation.
17 July 2023
Many still think of ZoBio as an NMR company. And while NMR will always have a special place in our hearts, we also have a thriving crystallography team!
Detailed and timely structural information is a cornerstone of rational drug design and X-ray crystallography plays a key role in most…
27 June 2023
ZoBio’s commitment to providing high-quality and efficient services is exemplified by our continued investment in advanced laboratory equipment that caters to our customers’ needs. One such piece of equipment we have been using for some time is the Hamilton Liquid Handler, which has proven…
ZoBio is pleased to announce that we have recently taken delivery of our fifth Biacore™ SPR instrument. Biacore 1S+ is one of the first of this newly developed platform to be delivered in Europe and will allow our Assays Group to further expand their leading breadth and depth of methods…